Saxon Interests Inc. Has $973,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Saxon Interests Inc. decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 63.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,848 shares of the healthcare conglomerate's stock after selling 3,212 shares during the quarter. Saxon Interests Inc.'s holdings in UnitedHealth Group were worth $973,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. State Street Corp lifted its stake in UnitedHealth Group by 1.7% in the second quarter. State Street Corp now owns 46,313,751 shares of the healthcare conglomerate's stock valued at $22,260,241,000 after acquiring an additional 764,872 shares during the last quarter. Wellington Management Group LLP lifted its stake in UnitedHealth Group by 2.1% in the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate's stock valued at $12,715,790,000 after acquiring an additional 527,526 shares during the last quarter. Morgan Stanley lifted its stake in UnitedHealth Group by 13.8% in the fourth quarter. Morgan Stanley now owns 15,635,038 shares of the healthcare conglomerate's stock valued at $8,289,386,000 after acquiring an additional 1,893,192 shares during the last quarter. Moneta Group Investment Advisors LLC raised its position in shares of UnitedHealth Group by 100,076.4% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 11,823,820 shares of the healthcare conglomerate's stock valued at $6,268,753,000 after purchasing an additional 11,812,017 shares during the period. Finally, Alliancebernstein L.P. raised its position in shares of UnitedHealth Group by 3.5% in the second quarter. Alliancebernstein L.P. now owns 11,749,819 shares of the healthcare conglomerate's stock valued at $5,647,433,000 after purchasing an additional 399,739 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded up $1.60 during mid-day trading on Thursday, reaching $494.70. The company had a trading volume of 3,805,551 shares, compared to its average volume of 4,097,774. The company's 50 day simple moving average is $503.10 and its 200 day simple moving average is $518.61. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company has a market capitalization of $456.08 billion, a price-to-earnings ratio of 20.70, a P/E/G ratio of 1.34 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share for the quarter, beating analysts' consensus estimates of $5.98 by $0.18. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. During the same period last year, the company posted $5.34 EPS. The firm's quarterly revenue was up 14.1% compared to the same quarter last year. Analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group's payout ratio is 31.54%.

Wall Street Analyst Weigh In

UNH has been the topic of several research analyst reports. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $584.00 to $581.00 and set an "overweight" rating on the stock in a research report on Wednesday, January 17th. Bank of America reissued a "buy" rating and issued a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Oppenheimer reissued an "outperform" rating and issued a $610.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Erste Group Bank reaffirmed a "hold" rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $591.00 price target on shares of UnitedHealth Group in a research report on Friday, January 19th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group has an average rating of "Moderate Buy" and an average target price of $579.33.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now directly owns 32,289 shares of the company's stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the company's stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The disclosure for this sale can be found here. Company insiders own 0.35% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.